Physician profile
Bindu Bennuri
NPI 1063511202
$328.99
in general payments reported to CMS, 2019-2025
8 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.50 · 2021: $13.53 · 2022: $13.82 · 2023: $17.01 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166 · Education: $92.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.37 |
| Education | $92.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $95.72 | 2025 | Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $58.77 | 2025 | Dupixent |
| Amgen INC. | $55.46 | 2025 | Tezspire |
| Csl Behring | $42.50 | 2019 | |
| Glaxosmithkline, LLC. | $32.51 | 2023-2025 | Bexsero, Rotarix, Penmenvy |
| Pfizer INC. | $16.68 | 2025 | |
| Abbott Laboratories | $13.82 | 2022 | |
| Phadia US INC. | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindu Bennuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.